Display options
Share it on

Evid Based Complement Alternat Med. 2021 Feb 19;2021:5579327. doi: 10.1155/2021/5579327. eCollection 2021.

Renal-Protective Effects and Potential Mechanisms of Traditional Chinese Medicine after Ischemia-Reperfusion Injury.

Evidence-based complementary and alternative medicine : eCAM

Demin Liu, Songling Tang, Lu Gan, Wei Cui

Affiliations

  1. Cardiology Department, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China.
  2. Research Laboratory of Emergency Medicine, Department of Emergency Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.

PMID: 33680054 PMCID: PMC7910071 DOI: 10.1155/2021/5579327

Abstract

Renal ischemia-reperfusion (I/R) injury mainly causes acute kidney injury (AKI) after renal transplantation, trauma, sepsis, and hypovolemic shock. Patients with renal I/R injury are frequently associated with a poor prognosis. Traditional Chinese medicine (TCM) has been used for the prevention and treatment of various diseases in China and other Asian countries for centuries. Many studies have shown the protective effect of TCM on renal I/R injury, due to its diverse bioactive components. The potential mechanisms of TCMs on renal I/R injury include anti-inflammation, antioxidative effect, anti-cell death, downregulation of adhesion molecule expression, regulation of energy metabolism by restoring Na

Copyright © 2021 Demin Liu et al.

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

  1. Chin J Integr Med. 2014 Mar;20(3):200-8 - PubMed
  2. Sci Rep. 2018 Jun 15;8(1):9173 - PubMed
  3. Chin J Integr Med. 2019 Jan;25(1):37-44 - PubMed
  4. Acta Biochim Biophys Sin (Shanghai). 2020 Feb 3;52(2):125-132 - PubMed
  5. Biomed Pharmacother. 2018 Jul;103:1127-1136 - PubMed
  6. Oxid Med Cell Longev. 2016;2016:1737185 - PubMed
  7. Mol Med Rep. 2016 Feb;13(2):1353-60 - PubMed
  8. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Jan;37(1):57-66 - PubMed
  9. Mediators Inflamm. 2020 Nov 24;2020:8869511 - PubMed
  10. Oxid Med Cell Longev. 2015;2015:362158 - PubMed
  11. Exp Ther Med. 2014 May;7(5):1247-1252 - PubMed
  12. Food Chem Toxicol. 2016 Oct;96:215-25 - PubMed
  13. Clin Exp Pharmacol Physiol. 2005 Sep;32(9):742-8 - PubMed
  14. Front Pharmacol. 2020 Sep 03;11:541426 - PubMed
  15. Zhongguo Zhong Yao Za Zhi. 2014 Aug;39(16):3157-61 - PubMed
  16. Free Radic Res. 2019 Jul;53(7):727-736 - PubMed
  17. Mol Biol Rep. 2013 Mar;40(3):2347-55 - PubMed
  18. Am J Physiol Renal Physiol. 2018 Aug 1;315(2):F254-F262 - PubMed
  19. Transplant Proc. 2010 Jun;42(5):1545-9 - PubMed
  20. Transplant Proc. 2001 Sep;33(6):2986-7 - PubMed
  21. Int J Mol Sci. 2019 Dec 12;20(24): - PubMed
  22. Zhongguo Zhong Yao Za Zhi. 2020 Feb;45(3):617-622 - PubMed
  23. Bioorg Chem. 2020 Jan;94:103485 - PubMed
  24. Chin J Integr Med. 2012 Dec;18(12):918-24 - PubMed
  25. Transplant Proc. 2004 Sep;36(7):1949-51 - PubMed
  26. Basic Clin Pharmacol Toxicol. 2019 Nov;125(5):420-429 - PubMed
  27. J Nat Med. 2018 Jun;72(3):715-723 - PubMed
  28. Int J Mol Med. 2016 Jul;38(1):210-6 - PubMed
  29. Phytother Res. 2018 Jan;32(1):103-114 - PubMed
  30. Front Pharmacol. 2020 Sep 16;11:537147 - PubMed
  31. Shock. 2010 Sep;34(3):314-20 - PubMed

Publication Types